Skip to main content
Cellromax Science Co., Ltd. logo

Cellromax Science Co., Ltd. — Investor Relations & Filings

Ticker · 471820 ISIN · KR7471820001 KO Manufacturing
Open in API
Filings indexed 90 across all filing types
Latest filing 2025-07-08 Proxy Solicitation & In…
Country KR South Korea
Listing KO 471820

About Cellromax Science Co., Ltd.

https://www.cellromax.kr/

Cellromax Science Co., Ltd. is a company specializing in the research, development, and manufacturing of health-related products. Its portfolio is centered on three key areas: health functional foods, derma-cosmetics, and over-the-counter (OTC) pharmaceuticals. The company leverages scientific research and high-quality, naturally derived ingredients to create unique and effective products. Its development philosophy emphasizes optimized formulas and specialized prescriptions designed to support consumer health, skin vitality, and overall well-being.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting' (임시주주총회소집공고) issued by Cellromax Science. It details the meeting date, location, agenda items (capital reduction and treasury stock cancellation), and provides management reference materials (governance, board activities, and business overview). This document is a standard proxy solicitation material sent to shareholders to inform them of the meeting and request their participation/votes, which aligns with the definition of a Proxy Solicitation & Information Statement.
2025-07-08 Korean
신탁계약해지결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on the Termination of a Trust Agreement' (신탁계약해지결과보고서) filed by Cellromax Science. It details the results of a share buyback program conducted through a trust contract, including the acquisition of treasury shares and the final status of those shares after the contract termination. This falls under the category of 'Transaction in Own Shares' (POS), as it reports the company's activity regarding the acquisition and holding of its own shares.
2025-07-07 Korean
수시공시의무관련사항(공정공시) (주주가치 제고를 위한 주주환원계획 수립)
Notice of Dividend Amount Classification · 100% confidence The document is a 'Fair Disclosure' (공정공시) filing from Cellromax Science regarding a shareholder return policy (dividend plans and share buyback/cancellation). While it mentions dividends and share cancellation, it is a strategic announcement of a policy rather than a specific dividend declaration (DIV) or a transaction report (POS). As it is a regulatory disclosure of corporate policy, it fits best under the general regulatory filing category.
2025-06-13 Korean
주요사항보고서(감자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange regarding a 'Capital Reduction' (감자 결정). This involves a corporate action affecting the company's capital structure (share cancellation). According to the provided filing definitions, announcements regarding capital changes, share issues, or corporate restructuring of this nature fall under 'Share Issue/Capital Change' (SHA) or 'Regulatory Filings' (RNS). Given the specific nature of the capital reduction (share cancellation), 'SHA' is the most appropriate category for capital structure changes.
2025-06-13 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for Cellromax Science, detailing the date, location, and agenda items (capital reduction and share cancellation). This type of document is a standard proxy solicitation or meeting notice sent to shareholders to inform them of upcoming votes, which falls under the Proxy Solicitation & Information Statement category.
2025-06-13 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for an upcoming Extraordinary General Meeting (EGM). It does not contain the full proxy materials or the meeting results, but rather serves as a formal notification of the administrative step of closing the shareholder register. As it is a standard regulatory announcement regarding corporate governance procedures that does not fit into specific categories like 'DVA' (results) or 'PSI' (proxy solicitation materials), it is classified as a general regulatory filing.
2025-06-13 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.